Litcius/Paper detail

Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial

Rangasamy Ramanathan, Manoj Biniwale, Krishnamurthy Sekar, Nazeeh Hanna, Sergio Golombek, Jatinder Bhatia, Martha Naylor, Laura Fabbri, Guido Varoli, Debora Santoro, Dorothea Del Buono, Annalisa Piccinno, Christiane E.L. Dammann

2020The Journal of Pediatrics43 citationsDOI

Topics & Concepts

MedicineBronchopulmonary dysplasiaRespiratory distressFraction of inspired oxygenRandomized controlled trialAdverse effectContinuous positive airway pressureAnesthesiaGestational ageInternal medicineMechanical ventilationPregnancyObstructive sleep apneaGeneticsBiologyNeonatal Respiratory Health ResearchInfant Nutrition and HealthRespiratory Support and Mechanisms
Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial | Litcius